Page 141 - Annual report 2021-22
P. 141

Annual Report 2021-22 |


               GRANTS



               DU1                GENOMICS AND MOLECULAR MEDICINE

                                  DEVELOPMENT AND PILOT IMPLEMENTATION OF A GENETIC INFORMATION ACCESS AND ANALYSIS
               MLP2001                                                                                            124
                                  SYSTEM FOR GENETIC DISEASES (GenomeAPP)
               MLP2005            INTEGRATIVE GENomics OF COVID-19 (INGEN-CoV2)


                                  IDENTIFYING MODIFIERS OF GENETIC DISEASES FOR PREVENTIVE AND PROGNOSTIC INTERVENTIONS:
               MLP2010            FOCUS  ON  HEMATOLOGICAL  AND  NEUROLOGICAL  DISEASES  (GATII;  GENOMICS  ASSISTED  TARGET
                                  IDENTIFICATION AND INTERVENTION)


               GAP0127            PEDIATRIC RENAL BIOLOGY PROGRAM RESEARCH ON NEPHROTIC SYNDROME


                                  GENERATION  OF  INHERITABLE,  TRANSGENE-FREE  ABIOTIC  STRESS  (SALINITY  AND  DROUGHT)
               GAP0150
                                  TOLERANT AND SEMI-DWARF INDICA RICE CULTIVARS USING NEW PLANT BREEDING APPROACH

               GAP0168            CYCLIN DEPENDENT KINASE-5 (CDK5) MEDIATE UNFOLDED PROTEIN RESPONSE IN TYPE 2 DIABETES

                                  DECIPHERING  IDIOPATHIC  INTELLECTUAL  DISABILITY  (DIID)  THROUGH  NEXT  GENERATION
               GAP0174
                                  SEQUENCING (DIID-NGS STUDY)
               GAP0183            CENTRE OF EXCELLENCE FOR APPLIED DEVELOPMENT OF AYURVEDA, PRAKRITI AND GENOMICS

               GAP0187            ICMR ADVANCED CENTRE FOR RESEARCH IN PEDIATRIC KIDNEY DISEASES

                                  GENERATION OF NATURALLY OCCURRING BENEFICIAL HPFH MUTATIONS USING CRISPR-CAS9 BASED
               GAP0189            TARGETED GENOME EDITING TO REACTIVATE FETAL HEMOGLOBIN: AN STRATEGY FOR TREATING β-
                                  HEMOGLOBIN DISORDERS
               GAP0195            RNA GUIDED NUCLEASES BASED TARGETED GENOME EDITING FOR RETINITIS PIGMENTOSA

               GAP0206            GENOMEINDIA: CATALOGUING THE GENETIC VARIATION IN INDIANS

                                  DEVELOPMENT  OF  DIAGNOSTICS  AND  EXPERIMENTAL  THERAPEUTICS  USING  CRISPR-BASED
               GAP0209
                                  TECHNOLOGIES

                                  ESTABLISH ROBUST AND ECONOMICAL BLOOD-BASED PANEL OF DIAGNOSTIC BIOMARKERS FOR EARLY
               GAP0228
                                  DIAGNOSIS, DETECTION OF TUMOR PROGRESSION AND ITS RECURRENCE IN GLIOMAS

                                  GENOMIC SURVEILLANCE FOR SARS-COV-2 IN INDIA: INDIAN SARS-COV-2 GENOMICS CONSORTIUM
               GAP0231
                                  (INSACOG)

                                  A LARGE-SCALE COMPREHENSIVE CLINICAL AND GENOMICS APPROACH FOR RARE MUTATIONS AND
               GAP0240
                                  NOVEL GENE DISCOVERY IN HEREDITARY ATAXIAS IN INDIA-CHANGER

               CLP0032            GENETIC-EPIGENETIC INFLUENCE OVER DEXAMETHASONE RESPONSE AT HIGH-ALTITUDE

               OLP1120            GENOMICS AND OTHER OMICS TOOLS FOR ENABLING MEDICAL DECISION IN CLINICS (GOMED)

               OLP1154            PHARMACOGENOMICS ASSAY PANELS TO PREDICT DRUG RESPONSE IN COMPLEX DISORDERS

               DU2                CARDIO RESPIRATORY DISEASE BIOLOGY
   136   137   138   139   140   141   142   143   144   145   146